Supplement: Novel Cancer Immunotherapy Combos
Researchers Contextualize Immuno-Oncology Mechanisms to Advance Personalized Therapies
“Father of Gene Therapy” to be Released from Prison Next Month
W. French Anderson Intends to Resume a Career in Science
New Group Promotes AI, Robotics, and Automation in Healthcare
Goal Is to Improve Patient Access to Quality Care
Supplement: Cancer Immunotherapies Development Barriers
Current State of Protocol Design Impacting Small to Mid-Sized Biotech Companies
For full access to this article login to GEN Select now.
GEN Roundup: Kinase Assays: Too Many Are Never Enough
<i>GEN</i>'s Panel Gives Expert Advice on Which Format Is Best
- No drug developer imagines that every kinase-targeting program can be advanced by any single kinase assay format. Most drug developers recognize that if they are to advance a kinase-targeting program, they will have to sift through multiple kinase assay formats. In all likelihood, the drug developer will identify several ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.